These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 60761)
1. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes. Yachnin S Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2857-61. PubMed ID: 60761 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human lymphocyte transformation by human alpha-fetoprotein (HAFP); HAFP monomers and multimers and a resistant lymphocyte subpopulation. Yachnin S; Lester EP J Immunol; 1977 Aug; 119(2):555-7. PubMed ID: 69662 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression. Yachnin S; Lester E Clin Exp Immunol; 1976 Dec; 26(3):484-90. PubMed ID: 64327 [TBL] [Abstract][Full Text] [Related]
4. Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants. Lester EP; Miller JB; Yachnin S Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4645-8. PubMed ID: 63952 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels. Ren EC; Chan SH J Natl Cancer Inst; 1981 Apr; 66(4):625-30. PubMed ID: 6164810 [TBL] [Abstract][Full Text] [Related]
6. Lipid interactions with human alpha-fetoprotein (AFP). A study of the role of such interactions in the ability of human AFP to suppress lymphocyte transformation. Yachnin S; Getz GS; Lusk L; Hsu RC Oncodev Biol Med; 1980; 1(4-5):273-85. PubMed ID: 6169064 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism. Lester EP; Miller JB; Baron JM; Yachnin S Immunology; 1978 Feb; 34(2):189-98. PubMed ID: 75181 [TBL] [Abstract][Full Text] [Related]
8. Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity. Lester EP; Miller JB; Yachnin S Immunol Commun; 1978; 7(2):137-61. PubMed ID: 77248 [TBL] [Abstract][Full Text] [Related]
9. Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development. Yachnin S J Exp Med; 1975 Jan; 141(1):242-56. PubMed ID: 46911 [TBL] [Abstract][Full Text] [Related]
10. Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response. Parmely MJ; Thompson JS J Immunol; 1976 Nov; 117(5 Pt.2):1832-7. PubMed ID: 62791 [TBL] [Abstract][Full Text] [Related]
11. A postsynthetic modification of human alpha-fetoprotein controls its immunosuppressive potency. Lester EP; Miller JB; Yachnin S Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3988-92. PubMed ID: 71737 [TBL] [Abstract][Full Text] [Related]
12. Regulation of human lymphocyte activation by alpha-fetoprotein. Evidence for selective suppression of Ia-associated T-cell proliferation in vitro. O'Neill G; Tsega E; Gold P; Murgita RA Oncodev Biol Med; 1982; 3(2-3):135-50. PubMed ID: 6181483 [TBL] [Abstract][Full Text] [Related]
13. Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. Wang XP; Liu GZ; Song AL; Li HY; Liu Y World J Gastroenterol; 2004 Nov; 10(21):3197-200. PubMed ID: 15457574 [TBL] [Abstract][Full Text] [Related]
14. [Immune responses of dendritic cells after loaded with cytotoxicity T lymphocyte epitope based peptide of human alpha-fetoprotein (hAFP)]. Guo J; Cai M; Wei D; Qin L; Huang J; Wang X Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):178-80. PubMed ID: 12113671 [TBL] [Abstract][Full Text] [Related]
15. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas]. Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612 [TBL] [Abstract][Full Text] [Related]
16. E rosette formation in the presence of alpha-fetprotein and ferritin. Baumgarten A Clin Immunol Immunopathol; 1976 Jul; 6(1):42-6. PubMed ID: 59653 [No Abstract] [Full Text] [Related]
17. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576 [TBL] [Abstract][Full Text] [Related]
18. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401 [TBL] [Abstract][Full Text] [Related]
19. Stimulatory effect of human alpha-fetoprotein and its molecular variants on in-vitro-induced lymphocyte blastogenesis. Soubiran P; Mucchielli A; Kerckaert JP; Bayard B; Masseyeff R Scand J Immunol; 1979; 10(2):179-86. PubMed ID: 91191 [No Abstract] [Full Text] [Related]
20. Effect of alpha-fetoprotein and derived peptides on insulin- and estrogen-induced fetotoxicity. Butterstein G; Morrison J; Mizejewski GJ Fetal Diagn Ther; 2003; 18(5):360-9. PubMed ID: 12913349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]